Studies on post-mortem brains have shown increased microglial activation based on cell morphology and Iba1 and CD68 immunoreactivity in C9-FTLD and C9-ALS vs. sporadic FTLD and ALS cases. This evidence concerns the gene AIF1 and amyotrophic lateral sclerosis.